FI834305A - Foerfarande foer framstaellning av penemfoereningar. - Google Patents

Foerfarande foer framstaellning av penemfoereningar. Download PDF

Info

Publication number
FI834305A
FI834305A FI834305A FI834305A FI834305A FI 834305 A FI834305 A FI 834305A FI 834305 A FI834305 A FI 834305A FI 834305 A FI834305 A FI 834305A FI 834305 A FI834305 A FI 834305A
Authority
FI
Finland
Prior art keywords
compound
chem
hydrogen
formula
group
Prior art date
Application number
FI834305A
Other languages
English (en)
Other versions
FI834305A0 (fi
Inventor
Viyyoor Moopil Girijavallabhan
Ashit Kumar Ganguly
Patrick Anthony Pinto
Richard William Versace
Stuart Walter Mccombie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/445,295 external-priority patent/US4530793A/en
Priority claimed from US06/458,511 external-priority patent/US4435412A/en
Priority claimed from US06/461,845 external-priority patent/US4435413A/en
Priority claimed from US06/462,723 external-priority patent/US4456609A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI834305A0 publication Critical patent/FI834305A0/fi
Publication of FI834305A publication Critical patent/FI834305A/fi
Priority to FI865177A priority Critical patent/FI82698C/fi
Priority to FI865178A priority patent/FI80702C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pens And Brushes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Magnetic Variables (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
FI834305A 1982-11-29 1983-11-24 Foerfarande foer framstaellning av penemfoereningar. FI834305A (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI865177A FI82698C (fi) 1982-11-29 1986-12-18 Foerfarande foer framstaellning av penemfoereningar.
FI865178A FI80702C (fi) 1982-11-29 1986-12-18 Foerfarande foer framstaellning av antibakteriella tio-penem-3-karboxylsyror.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/445,295 US4530793A (en) 1982-11-29 1982-11-29 Processes for the production of penems
US06/458,511 US4435412A (en) 1982-11-29 1983-01-17 5R,6S,8R-2-(1-Methyl-2-imidazolylmethylthio)-6-(1-hydroxyethyl)penem-3-carboxylic acid
US06/461,845 US4435413A (en) 1983-01-28 1983-01-28 (5R-6S,8R)-6-(1-Hydroxyethyl)-2-(2-glycylaminoethylthio)-penem-3-carboxylic acid
US06/462,723 US4456609A (en) 1983-01-31 1983-01-31 (5R, 6S, 8R-6-(1-Hydroxyethyl)-2-(2-[methylaminocarbonyl]-ethylthio)-penem-3-carboxylic acid

Publications (2)

Publication Number Publication Date
FI834305A0 FI834305A0 (fi) 1983-11-24
FI834305A true FI834305A (fi) 1984-05-30

Family

ID=27503921

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834305A FI834305A (fi) 1982-11-29 1983-11-24 Foerfarande foer framstaellning av penemfoereningar.

Country Status (14)

Country Link
EP (2) EP0110280B1 (fi)
JP (1) JPH0631254B2 (fi)
KR (1) KR880002512B1 (fi)
AT (1) ATE112778T1 (fi)
AU (1) AU575545B2 (fi)
DE (1) DE3382761T2 (fi)
DK (1) DK166152C (fi)
FI (1) FI834305A (fi)
GR (1) GR81289B (fi)
HU (1) HU194889B (fi)
IL (1) IL70327A0 (fi)
NO (1) NO165073C (fi)
NZ (1) NZ206389A (fi)
PT (1) PT77712B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2159519B (en) * 1982-03-26 1986-08-20 Hoechst Uk Ltd 7-oxo-4-thia-1-azabicyclo3,2,0heptane derivatives; azetidinones
EP0091576B1 (en) * 1982-03-26 1987-07-29 Hoechst Uk Limited 7-oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives
EP0320497A1 (en) * 1983-01-25 1989-06-14 Merck & Co. Inc. Substituted 2-thioxopenams, intermediates therefrom and process for preparing substituted 2-thioxopenams and 2-substituted thiopenems
DK141784A (da) * 1983-03-14 1984-09-15 Schering Corp Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
YU44241B (en) * 1983-10-14 1990-04-30 Pfizer Process for making derivatives of 2-azacyclothiopenem
US4772597A (en) * 1983-10-14 1988-09-20 Pfizer Inc. 2-azacycloalkylthiopenem derivatives
US4584133A (en) * 1983-11-07 1986-04-22 Schering Corporation Process for the production of penems
US4782145A (en) * 1986-06-02 1988-11-01 Pfizer Inc. Process for penem derivatives
US4767853A (en) * 1986-07-21 1988-08-30 Schering Corporation Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof
PH24872A (en) * 1986-08-25 1990-12-26 Schering Corp (5r,6s,8r)-6-(-1-hydroxyethyl)-2-(3r-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid
US4992543A (en) * 1988-10-19 1991-02-12 Pfizer Inc. Penem derivatives
JP2559649B2 (ja) * 1991-08-30 1996-12-04 茂 只野 薬草入浴剤の製造方法
US11084833B2 (en) 2016-10-10 2021-08-10 The Johns Hopkins University Antibacterial agents against D,D- and L,D-transpeptidases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB207453A (en) * 1923-03-10 1923-11-29 Thomas Ford Improvements in automatic stapling, label tacking machines and the like
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
EP0042026B1 (de) * 1978-02-02 1986-01-08 Ciba-Geigy Ag 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
DE3070269D1 (en) * 1979-08-10 1985-04-18 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
JPS56142282A (en) * 1980-03-10 1981-11-06 Sankyo Co Ltd Penem-3-carboxylic acid derivative and its preparation
SE8101464L (sv) * 1980-03-10 1981-09-11 Sankyo Co 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
JPS572292A (en) * 1980-06-06 1982-01-07 Sankyo Co Ltd Production of penem-3-carboxylic derivative
GB2083462B (en) * 1980-08-16 1984-05-02 Beecham Group Ltd 2-thiopenem derivatives
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
IT1190842B (it) * 1981-06-30 1988-02-24 Erba Farmitalia Via di sintesi di derivati otticamente attivi dell'acido 2-penem-3-carbossilico
JPS588084A (ja) * 1981-07-08 1983-01-18 Takeda Chem Ind Ltd (6r)−置換−(5r)−ペネム−3−カルボン酸誘導体およびその製造法
EP0180252B1 (en) * 1981-07-15 1989-04-26 Sumitomo Pharmaceuticals Company, Limited Process of preparing azetidinone compounds
JPS5835190A (ja) * 1981-08-25 1983-03-01 Sankyo Co Ltd ペネム−3−カルボン酸誘導体
CA1190236A (en) * 1981-10-23 1985-07-09 Edward J.J. Grabowski Antibiotic synthesis
US4411906A (en) * 1981-11-25 1983-10-25 Schering Corporation (5R,6S,8R)-6-(1-Hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylates
EP0087792A1 (en) * 1982-03-01 1983-09-07 Merck & Co. Inc. 6-Substituted-2-carbamimidoyl-pen-2-em-3-carboxylic acids, process for preparing them and antibiotic compositions comprising them

Also Published As

Publication number Publication date
GR81289B (fi) 1984-12-11
NZ206389A (en) 1986-10-08
JPH0631254B2 (ja) 1994-04-27
AU575545B2 (en) 1988-08-04
JPS59108789A (ja) 1984-06-23
NO834331L (no) 1984-05-30
HU194889B (en) 1988-03-28
DK538183D0 (da) 1983-11-24
NO165073B (no) 1990-09-10
DE3382761D1 (de) 1994-11-17
PT77712B (en) 1986-05-12
DE3382761T2 (de) 1995-03-09
EP0345827A1 (en) 1989-12-13
IL70327A0 (en) 1984-02-29
EP0110280B1 (en) 1994-10-12
NO165073C (no) 1990-12-19
AU2167683A (en) 1984-06-07
ATE112778T1 (de) 1994-10-15
PT77712A (en) 1983-12-01
DK538183A (da) 1984-05-30
FI834305A0 (fi) 1983-11-24
KR840006807A (ko) 1984-12-03
DK166152B (da) 1993-03-15
DK166152C (da) 1993-08-09
EP0110280A1 (en) 1984-06-13
KR880002512B1 (ko) 1988-11-26

Similar Documents

Publication Publication Date Title
FI834305A (fi) Foerfarande foer framstaellning av penemfoereningar.
FI913640A (fi) Foerfarande foer framstaellning av nitriler.
HU9503719D0 (en) Piperidine derivatives and process for their production
ATE181919T1 (de) Camptothecinderivat und dessen verwendung als antitumormittel
ATE150463T1 (de) Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
IE781382L (en) Indole derivatives
ES8705386A1 (es) Un procedimiento para la produccion estereoespecifia de un compuesto de b-lactama.
EP0050671A4 (en) THIAZOLE (3,2-a) PYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM.
WO1993004059A1 (en) 4-acylaminoimidazole derivative
IE851853L (en) Azetidinones.
KR930016414A (ko) 신규의 4-신놀리닐-및 4-나프티리디닐-디히드로피리딘, 그들의 제조 방법 및 약제로서 그들의 용도
JPS57167964A (en) Preparation of (4r)-3-substituted-4-(substituted or unsubstituted carboxymethyl)-2-azetidinone derivative
MX9700003A (es) Proceso para la reparacion de derivados de ??cido-clorometil-fenilglioxilico.
FI861630A (fi) Derivat av 6-(1-acyl-1-hydroximetyl) penicillansyra.
DE69323894T2 (de) Verfahren zur herstellung von provitamin-d-verbindungen
MY105332A (en) Process for preparing penem esters
DE3864163D1 (de) Beta-lactam-verbindungen und verfahren zu deren herstellung.
ES8200104A1 (es) Procedimiento de obtencion de la 5,11-dihidro-11-(4-metil- piperacin-1-il)-acetil)-6h-pirido(2,3-b) (1,k4)benzodiazepin-6-ona y sus sales
KR860009016A (ko) 항비루스 화합물의 제조방법

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SCHERING CORPORATION